세계의 유전체학 시장 규모, 점유율, 성장 분석 : 제공별, 제품 유형별, 기술별, 서비스 유형별, 용도별, 연구 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Genomics Market Size, Share, and Growth Analysis, By Offering, By Product Type, By Technology, By Service Type, By Application, By Study Type, By End User, By Region - Industry Forecast 2025-2032
유전체학 시장 규모는 2023년 371억 달러, 2024년 416억 6,000만 달러에서 2032년에는 1,053억 9,000만 달러로 성장하고, 예측 기간(2025-2032년) 동안 12.3%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
유전체학 분야는 DNA의 구조, 기능 및 매핑에 대한 이해의 진전에 힘입어 놀라운 변화를 겪고 있습니다. 전 세계적으로 암 발병률이 증가함에 따라 정부의 지원도 증가하여 혁신적인 유전체학 프로젝트에 자금이 지원되고 있습니다. 이러한 급증은 개인 맞춤형 의료의 출현을 가능하게 하고, 임상 종양학 및 희귀 유전성 질환의 치료 전략에 혁명을 일으키고 있습니다. 동시에 학계는 유전학과 인지 장애의 상관관계를 탐구하고 유전체학의 적용을 더욱 확장하고 있습니다. 암 연구에 대한 관심 증가, 신속한 임상 진단에 대한 수요, 정부 기관 및 바이오 제약사의 활발한 투자로 인해 유전체학 시장은 빠른 속도로 성장하고 있습니다. 이러한 다각적인 진화는 유전체학이 헬스케어 및 의료 과학에 미치는 큰 영향을 반영하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 특허 분석
- 규제 분석
- 기술 분석
- 사례 연구
유전체학 시장 규모 : 제공별
유전체학 시장 규모 : 제품 유형별
- 시장 개요
- 시약, 키트 및 소모품
- 기기
- 바이오인포매틱스 툴
유전체학 시장 규모 : 기술별
- 시장 개요
- 시퀀싱
- PCR
- 유전자 편집
- 유세포분석기
- 마이크로어레이
- In Situ Hybridization
- 기타 기술
유전체학 시장 규모 : 서비스 유형별
- 시장 개요
- 유전체 프로파일링 및 시퀀싱 서비스
- 샘플 조제 및 라이브러리 조제 서비스
- 바이오인포매틱스 서비스
유전체학 시장 규모 : 용도별
- 시장 개요
- Drug Discovery & Development
- 진단
- 감염증
- 생식 보건
- 기타 진단 용도
- 농업 및 동물 연구
- 기타 용도
유전체학 시장 규모 : 연구 유형별
- 시장 개요
- 기능적 유전체학
- 바이오마커 발견
- 패스웨이 분석
- 에피유전체학
- 기타 연구 유형
유전체학 시장 규모 : 최종사용자별
- 시장 개요
- 병원, 진단 실험실 및 진료소
- 학술연구기관
- 제약 및 바이오테크놀러지 기업
- 기타 최종사용자
유전체학 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 상세
- 제품 포트폴리오 분석
- 기업 부문별 점유율 분석
- 매출 전년대비 비교(2022-2024년)
주요 기업 개요
- Illumina, Inc.(US)
- Thermo Fisher Scientific(US)
- Qiagen N.V.(Netherlands)
- BGI Group(China)
- F. Hoffmann-La Roche AG(Switzerland)
- Danaher Corporation(US)
- Pacific Biosciences of California, Inc.(US)
- Oxford Nanopore Technologies, Ltd.(United Kingdom)
- Eurofins Scientific SE(Luxembourg)
- Bio-Rad Laboratories, Inc.(US)
- Myriad Genetics, Inc.(US)
- Fluidigm Corporation(US)
- PerkinElmer, Inc.(US)
- Twist Bioscience Corporation(US)
- Natera, Inc.(US)
- Veracyte, Inc.(US)
- Personalis, Inc.(US)
- 10x Genomics, Inc.(US)
- Quest Diagnostics(US)
결론과 제안
LSH
Genomics Market size was valued at USD 37.1 billion in 2023 and is poised to grow from USD 41.66 billion in 2024 to USD 105.39 billion by 2032, growing at a CAGR of 12.3% during the forecast period (2025-2032).
The genomics sector is witnessing significant transformation, driven by advancements in the understanding of DNA structure, function, and mapping. As the global incidence of cancer escalates, so does government support, with increased funding fueling innovative genomics projects. This surge has enabled the emergence of personalized medicine, revolutionizing treatment strategies in clinical oncology and rare genetic disorders. Concurrently, academia is delving into the correlations between genetics and cognitive disorders, further expanding genomics applications. The heightened focus on cancer research, coupled with a demand for expedited clinical diagnostics and robust investments from government bodies and biopharmaceutical firms, is propelling the genomics market towards rapid revenue growth. This multifaceted evolution reflects the profound impact genomics has on healthcare and medical sciences.
Top-down and bottom-up approaches were used to estimate and validate the size of the Genomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Genomics Market Segments Analysis
Global Genomics Market is segmented by Offering, Product Type, Technology, Service Type, Application, Study Type, End User and region. Based on Offering, the market is segmented into Products and Services. Based on Product Type, the market is segmented into Reagents, Kits, And Consumables, Instruments and Bioinformatics Tools. Based on Technology, the market is segmented into Sequencing, PCR, Gene Editing,Flow Cytometry, Microarrays, In Situ Hybridization and Other Technologies. Based on Service Type, the market is segmented into Genomic Profiling and Sequencing Services, Sample Preparation and Library Preparation Services and Bioinformatics Services. Based on Application, the market is segmented into Drug Discovery and Development, Diagnostics and Other Applications. Based on Study Type, the market is segmented into Functional Genomics, Biomarker Discovery, Pathway Analysis, Epigenomics and Other Study Types. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories, and Clinics, Academic and Research Institutes, Pharmaceutical And Biotechnology Companies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Genomics Market
The Genomics market is experiencing significant growth due to the expanding utilization of Next-Generation Sequencing (NGS) in various applications, particularly in cancer research. This technology encompasses a range of uses, including whole-genome sequencing, the exploration of genomic diversity, metagenomics, epigenetic studies, the identification of non-coding RNAs and protein-binding sites, as well as gene-expression profiling via RNA sequencing. Each of these applications enhances our understanding of genetics and disease, thereby fueling demand in the Genomics market. The increasing reliance on NGS technologies signifies their crucial role in advancing genomic studies and innovations.
Restraints in the Genomics Market
The genomics market is facing potential challenges, particularly regarding the availability of skilled personnel, which is a common constraint in many industries. Additionally, the high costs associated with genomic equipment and the complexities of data storage-stemming from sequenced data between 2023 and 2031-may hinder market growth. While the incorporation of genomic technologies in healthcare has the capacity to improve safety, quality, efficiency, and overall cost-effectiveness, realizing these advantages is heavily contingent upon having access to qualified professionals. Thus, without addressing these limitations, the expansion and effectiveness of the genomics market could be significantly impacted.
Market Trends of the Genomics Market
The genomics market is witnessing a pivotal shift as Illumina phases out its OmniExpress chip in favor of the customized Global Screening Array (GSA) microarray. This transition is compelling companies like Ancestry.com to adapt quickly by either adopting the GSA, integrating Thermo Fisher Scientific products, or investing in next-generation sequencing (NGS) technology. This trend underscores a broader movement within the genomics industry toward enhanced precision, scalability, and cost-effectiveness in genetic analysis. As organizations pivot to maintain competitive advantages, the demand for innovative sequencing solutions is expected to accelerate, driving growth and transformation in the genomics landscape.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Patent Analysis
- Regulatory Analysis
- Technology Analysis
- Case Studies
Global Genomics Market Size by Offering & CAGR (2025-2032)
- Market Overview
- Products
- Services
Global Genomics Market Size by Product Type & CAGR (2025-2032)
- Market Overview
- Reagents, Kits, And Consumables
- Instruments
- Bioinformatics Tools
Global Genomics Market Size by Technology & CAGR (2025-2032)
- Market Overview
- Sequencing
- PCR
- Gene Editing
- Flow Cytometry
- Microarrays
- In Situ Hybridization
- Other Technologies
Global Genomics Market Size by Service Type & CAGR (2025-2032)
- Market Overview
- Genomic Profiling and Sequencing Services
- Sample Preparation and Library Preparation Services
- Bioinformatics Services
Global Genomics Market Size by Application & CAGR (2025-2032)
- Market Overview
- Drug Discovery and Development
- Diagnostics
- Infectious Diseases
- Reproductive Health
- Other Diagnostic Applications
- Agriculture And Animal Research
- Other Applications
Global Genomics Market Size by Study Type & CAGR (2025-2032)
- Market Overview
- Functional Genomics
- Biomarker Discovery
- Pathway Analysis
- Epigenomics
- Other Study Types
Global Genomics Market Size by End User & CAGR (2025-2032)
- Market Overview
- Hospitals, Diagnostic Laboratories, and Clinics
- Academic and Research Institutes
- Pharmaceutical And Biotechnology Companies
- Other End Users
Global Genomics Market Size & CAGR (2025-2032)
- North America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- Europe (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Offering, Product Type, Technology, Service Type, Application, Study Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pacific Biosciences of California, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies, Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Myriad Genetics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Twist Bioscience Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Natera, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Veracyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Personalis, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 10x Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
